Cargando…

Lung Transplantation for Idiopathic Pulmonary Fibrosis

Despite advances in the development of novel pharmaceutical agents to treat idiopathic pulmonary fibrosis (IPF), there are no medical therapies known to resolve fibrosis or improve lung function in IPF. Therefore, lung transplantation remains the only life-saving therapy available to treat patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lamas, Daniela J., Lederer, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121325/ http://dx.doi.org/10.1007/978-1-62703-682-5_18

Ejemplares similares

Lung Transplantation in Idiopathic Pulmonary Fibrosis
por: Laporta Hernandez, Rosalía, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
por: Balestro, Elisabetta, et al.
Publicado: (2019)

Lung cancer in idiopathic pulmonary fibrosis patients diagnosed during or after lung transplantation()
por: Hendriks, L.E.L., et al.
Publicado: (2012)

Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature
por: Kistler, Kristin D, et al.
Publicado: (2014)

Pulmonary rehabilitation improves survival in patients with idiopathic pulmonary fibrosis undergoing lung transplantation
por: Florian, Juliessa, et al.
Publicado: (2019)

Antifibrotic therapy in idiopathic pulmonary fibrosis candidates for lung transplantation undergoing pulmonary rehabilitation
por: Pereira, Monica Pruss, et al.
Publicado: (2023)

Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
por: Case, Amy Hajari, et al.
Publicado: (2020)

Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis
por: Astor, Todd L., et al.
Publicado: (2023)

Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
por: Kreuter, Michael, et al.
Publicado: (2019)

Functional improvement in patients with idiopathic pulmonary fibrosis undergoing single lung transplantation
por: Rubin, Adalberto Sperb, et al.
Publicado: (2015)

Ambulatory oxygen therapy in lung transplantation candidates with idiopathic pulmonary fibrosis referred for pulmonary rehabilitation
por: Miozzo, Aline Paula, et al.
Publicado: (2023)

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
por: Zmijewski, Jaroslaw W., et al.
Publicado: (2022)

Physiology of the lung in idiopathic pulmonary fibrosis
por: Plantier, Laurent, et al.
Publicado: (2018)

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
por: Lancaster, Lisa, et al.
Publicado: (2020)

Does continuation of antifibrotics before lung transplantation influence post-transplant outcomes in patients with idiopathic pulmonary fibrosis?
por: Zhu, Michael Z L, et al.
Publicado: (2021)

RNA sequencing of transplant-stage idiopathic pulmonary fibrosis lung reveals unique pathway regulation
por: Sivakumar, Pitchumani, et al.
Publicado: (2019)

Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016–2020
por: López-Muñiz Ballesteros, Belén, et al.
Publicado: (2023)

Invadosome Formation by Lung Fibroblasts in Idiopathic Pulmonary Fibrosis
por: Lebel, Mégane, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis
por: Nuovo, Gerard J., et al.
Publicado: (2011)

Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry
por: Swaminathan, Aparna C., et al.
Publicado: (2022)

Inescapable Fibrosis: The Development of Desquamative Interstitial Pneumonia Post-Lung Transplantation Performed for a Patient with Idiopathic Pulmonary Fibrosis
por: Lilburn, Paul, et al.
Publicado: (2023)

The reliability of lung ultrasound in assessment of idiopathic pulmonary fibrosis
por: Manolescu, Diana, et al.
Publicado: (2018)

Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients
por: Tong, Xunliang, et al.
Publicado: (2019)

Lung function trajectories in patients with idiopathic pulmonary fibrosis
por: Neely, Megan L, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
por: Delanote, Isabelle, et al.
Publicado: (2016)

Single versus bilateral lung transplantation in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
por: Li, Diandian, et al.
Publicado: (2020)

Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
por: Wang, Xiao Mei, et al.
Publicado: (2006)

A model of the aged lung epithelium in idiopathic pulmonary fibrosis
por: Shaghaghi, Hoora, et al.
Publicado: (2021)

Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study
por: Gershman, Evgeni, et al.
Publicado: (2020)

Pulmonary nocardiosis following COVID-19 in a patient with idiopathic pulmonary fibrosis and lung transplantation: a case report
por: Cao, Liming, et al.
Publicado: (2023)

Cough in idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2016)

Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation
por: Maher, Toby M., et al.
Publicado: (2019)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Amati, Francesco, et al.
Publicado: (2022)

Nintedanib prevented fibrosis progression and lung cancer growth in idiopathic pulmonary fibrosis
por: Fukunaga, Kentaro, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks
por: Patrucco, Filippo, et al.
Publicado: (2023)

Idiopathic Pulmonary Fibrosis and Lung Cancer: Finding Similarities within Differences
por: Reyfman, Paul A., et al.
Publicado: (2019)

Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design
por: Santermans, Eva, et al.
Publicado: (2019)

Smoking and Idiopathic Pulmonary Fibrosis
por: Oh, Chad K., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f5ne66ialiv80sfl1sns1p5skq